The chemical substance with the name "(6aR,8R,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol" and CAS number "52522-55-1" is a complex organic compound characterized by its unique bicyclic structure, which includes a dibenzo[b,d]pyran moiety. This compound features multiple stereocenters, contributing to its chiral nature, and exhibits a range of functional groups, including hydroxyl (-OH) groups, which can influence its solubility and reactivity. The presence of a pentyl chain and dimethyl groups enhances its hydrophobic characteristics, potentially affecting its biological activity and interaction with lipid membranes. The stereochemistry indicated by the (6aR,8R,10aR) configuration suggests specific spatial arrangements that may play a crucial role in its pharmacological properties. Overall, this compound may exhibit interesting biological activities, making it a subject of interest in medicinal chemistry and pharmacology, although specific biological effects would require further investigation.

8β-hydroxy-exo-THC  is an analytical reference standard that is structurally similar to known phytocannabinoids. 8β-hydroxy-exo-THC is a metabolite of exo-THC .
1
8β-hydroxy-exo-THC is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.

(6aR,8R,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol

52522-55-1: The chemical substance with the name "(6aR,8R,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol" and CAS number "52522-55-1" is a complex organic compound characterized by its unique bicyclic structure, which includes a dibenzo[b,d]pyran moiety. This compound features multiple stereocenters, contributing to its chiral nature, and exhibits a range of functional groups, including hydroxyl (-OH) groups, which can influence its solubility and reactivity. The presence of a pentyl chain and dimethyl groups enhances its hydrophobic characteristics, potentially affecting its biological activity and interaction with lipid membranes. The stereochemistry indicated by the (6aR,8R,10aR) configuration suggests specific spatial arrangements that may play a crucial role in its pharmacological properties. Overall, this compound may exhibit interesting biological activities, making it a subject of interest in medicinal chemistry and pharmacology, although specific biological effects would require further investigation.

<p>8β-Hydroxy-exo-THC, a cannabinoid ether analog, exhibits weak affinity for receptor sites with an IC50 of 1.2 μM.</p>

CAS 52522-55-1

(6aR,8R,10aR)-6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol

8β-Hydroxy-exo-THC

Ref: TM-T203451